Abstract:This working paper is hosted by The Berkeley Electronic Press (bepress) and may not be commercially reproduced without the permission of the copyright holder. Summary. Randomized clinical trials are a powerful tool for investigating causal treatment effects, but in human trials there are oftentimes problems of noncompliance which standard analyses, such as the intention-to-treat or as-treated analysis, either ignore or incorporate in such a way that the resulting estimand is no longer a causal effect. One alternative to these analyses is the complier average causal effect (CACE) which estimates the average causal treatment effect among a subpopulation that would comply under any treatment assigned. We focus on the setting of a randomized clinical trial with crossover treatment noncompliance (e.g., control subjects could receive the intervention and intervention subjects could receive the control) and outcome nonresponse. In this article, we develop estimators for the CACE using multiple imputation methods, which have been successfully applied to a wide variety of missing data problems, but have not yet been applied to the potential outcomes setting of causal inference. Using simulated data we investigate the finite sample properties of these estimators as well as of competing procedures in a simple setting. Finally we illustrate our methods using a real randomized encouragement design study on the effectiveness of the influenza vaccine. 1. Introduction The focus of empirical studies in medicine is often to estimate the causal effect of treatments, where randomized clinical trials are considered the most acceptable tool for investigating these causal relationships. But in trials involving human subjects there are oftentimes problems of patient noncompliance, where the patient does not adhere to the treatment assigned. In addition, there is also the problem of nonignorable missing data, where the missing-data mechanism may depend on unobserved data. Standard methods and analyses either ignore these complications, which can lead to biased estimates of causal treatment effect, or account for them in such a way that the resulting estimand can no longer be considered a causal effect of treatment. A statistical framework for causal inference that deals with the issue of noncompliance is based on potential outcomes and was first introduced by Neyman (1923) for randomized studies and later developed by Rubin (1974, 1978) for nonrandomized studies and other forms of inference. Rubin's approach, sometimes referred to as the Ru-bin Causal Model (Holland, 1986), provides a framework for defining the parameters of interest and correctly attributing the …

Bayesian Analysis of the Causal Effect in Clinical Trials with Ordered Compliance

Bounds On Causal Effects In Three-Arm Trials With Non-Compliance

Bayesian Inference for Causal Effects in Randomized Experiments with Noncompliance

Bayesian Causal Inference in Sequentially Randomized Experiments with Noncompliance

Bayesian Phase II Clinical Trial Design with Noncompliance

Estimating the Causal Effects in Randomized Trials for Survival Data with A Cure Fraction and Non Compliance

A Bayesian Classification Trees Approach to Treatment Effect Variation with Noncompliance

Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome

Clustered Encouragement Designs with Individual Noncompliance: Bayesian Inference with Randomization, and Application to Advance Directive Forms

Bayesian analysis of longitudinal studies with treatment by indication

Bayesian Approach for Design and Analysis of Medical Device Trials in the Era of Modern Clinical Studies

A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks

Conditional and Unconditional Treatment Effects in Randomized Clinical Trials: Estimands, Estimation, and Interpretation

Causal inference in paired two-arm experimental studies under non-compliance with application to prognosis of myocardial infarction

A Bayesian Response-Adaptive Covariate-Balanced Randomization Design with Application to A Leukemia Clinical Trial

A Bayesian Dose Finding Design for Oncology Clinical Trials of Combinational Biological Agents

Joint Estimation of Treatment and Placebo Effects in Clinical Trials with Longitudinal Blinding Assessments

Identifiability and Estimation of Causal Effects in Randomized Trials with Noncompliance and Completely Nonignorable Missing Data

Principal Stratification for Causal Inference with Extended Partial Compliance

Series 2-19-2009 Multiple Imputation Methods for Treatment Noncompliance and Nonresponse in Randomized Clinical Trials